BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

651 related articles for article (PubMed ID: 31049932)

  • 21. Association of ACE inhibitors and angiotensin receptor blockers with keratinocyte cancer prevention in the randomized VATTC trial.
    Christian JB; Lapane KL; Hume AL; Eaton CB; Weinstock MA;
    J Natl Cancer Inst; 2008 Sep; 100(17):1223-32. PubMed ID: 18728281
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Capecitabine for skin cancer prevention in solid organ transplant recipients.
    Jirakulaporn T; Endrizzi B; Lindgren B; Mathew J; Lee PK; Dudek AZ
    Clin Transplant; 2011; 25(4):541-8. PubMed ID: 21050273
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sirolimus use and risk of cutaneous squamous cell carcinoma (SCC) in solid organ transplant recipients (SOTRs).
    Asgari MM; Arron ST; Warton EM; Quesenberry CP; Weisshaar D
    J Am Acad Dermatol; 2015 Sep; 73(3):444-50. PubMed ID: 26138646
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Risk of skin cancer and other malignancies in kidney, liver, heart and lung transplant recipients 1970 to 2008--a Swedish population-based study.
    Krynitz B; Edgren G; Lindelöf B; Baecklund E; Brattström C; Wilczek H; Smedby KE
    Int J Cancer; 2013 Mar; 132(6):1429-38. PubMed ID: 22886725
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Incidence trends of keratinocytic skin cancers and melanoma in Israel 2006-11.
    Sella T; Goren I; Shalev V; Shapira H; Zandbank J; Rosenblum J; Kimlin MG; Chodick G
    Br J Dermatol; 2015 Jan; 172(1):202-7. PubMed ID: 24976239
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Increasing skin cancer incidence in young, affluent, urban populations: a challenge for prevention.
    Deady S; Sharp L; Comber H
    Br J Dermatol; 2014 Aug; 171(2):324-31. PubMed ID: 24666396
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Post-transplant malignancy in solid organ transplant recipients in Ireland, The Irish Transplant Cancer Group.
    O'Neill JP; Sexton DJ; O'Leary E; O'Kelly P; Murray S; Deady S; Daly F; Williams Y; Dean B; Fitzgerald C; Murad A; Mansoor N; O'Neill JO; Egan J; Houlihan DD; McCormick PA; Morris PG; Ni Raghallaigh S; Little D; Moloney FJ; Conlon PJ
    Clin Transplant; 2019 Oct; 33(10):e13669. PubMed ID: 31310037
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Azathioprine and Risk of Skin Cancer in Organ Transplant Recipients: Systematic Review and Meta-Analysis.
    Jiyad Z; Olsen CM; Burke MT; Isbel NM; Green AC
    Am J Transplant; 2016 Dec; 16(12):3490-3503. PubMed ID: 27163483
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Polygenic Risk Scores Stratify Keratinocyte Cancer Risk among Solid Organ Transplant Recipients with Chronic Immunosuppression in a High Ultraviolet Radiation Environment.
    Seviiri M; Law MH; Ong JS; Gharahkhani P; Nyholt DR; Hopkins P; Chambers D; Campbell S; Isbel NM; Soyer HP; Olsen CM; Ellis JJ; Whiteman DC; Green AC; MacGregor S
    J Invest Dermatol; 2021 Dec; 141(12):2866-2875.e2. PubMed ID: 34089721
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Belatacept reduces skin cancer risk in kidney transplant recipients.
    Wang M; Mittal A; Colegio OR
    J Am Acad Dermatol; 2020 Apr; 82(4):996-998. PubMed ID: 31589945
    [No Abstract]   [Full Text] [Related]  

  • 31. Skin Cancer Development in Solid Organ Transplant Recipients in Switzerland (Swiss Transplant Cohort Study).
    Stenz NA; Stampf S; Arnold AW; Cozzio A; Dickenmann M; Gaide O; Harms M; Hunger RE; Laffitte E; Mühlstädt M; Nägeli M; Hofbauer GFL;
    Dermatology; 2021; 237(6):970-980. PubMed ID: 33227788
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A population-based study of skin cancer incidence and prevalence in renal transplant recipients.
    Moloney FJ; Comber H; O'Lorcain P; O'Kelly P; Conlon PJ; Murphy GM
    Br J Dermatol; 2006 Mar; 154(3):498-504. PubMed ID: 16445782
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Aspirin and nonsteroidal anti-inflammatory drug use and keratinocyte cancers: a large population-based cohort study of skin cancer in Australia.
    Pandeya N; Olsen CM; Thompson BS; Dusingize JC; Neale RE; Green AC; Whiteman DC;
    Br J Dermatol; 2019 Oct; 181(4):749-760. PubMed ID: 30920641
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Incidence of and Risk Factors for Skin Cancer in Organ Transplant Recipients in the United States.
    Garrett GL; Blanc PD; Boscardin J; Lloyd AA; Ahmed RL; Anthony T; Bibee K; Breithaupt A; Cannon J; Chen A; Cheng JY; Chiesa-Fuxench Z; Colegio OR; Curiel-Lewandrowski C; Del Guzzo CA; Disse M; Dowd M; Eilers R; Ortiz AE; Morris C; Golden SK; Graves MS; Griffin JR; Hopkins RS; Huang CC; Bae GH; Jambusaria A; Jennings TA; Jiang SI; Karia PS; Khetarpal S; Kim C; Klintmalm G; Konicke K; Koyfman SA; Lam C; Lee P; Leitenberger JJ; Loh T; Lowenstein S; Madankumar R; Moreau JF; Nijhawan RI; Ochoa S; Olasz EB; Otchere E; Otley C; Oulton J; Patel PH; Patel VA; Prabhu AV; Pugliano-Mauro M; Schmults CD; Schram S; Shih AF; Shin T; Soon S; Soriano T; Srivastava D; Stein JA; Sternhell-Blackwell K; Taylor S; Vidimos A; Wu P; Zajdel N; Zelac D; Arron ST
    JAMA Dermatol; 2017 Mar; 153(3):296-303. PubMed ID: 28097368
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Skin lesions in organ transplant recipients: a study of 177 consecutive Brazilian patients.
    Oliveira WRP; Tirico MCCP; Souza AAV; Codarin FR; Silva LLC; Festa Neto C
    Int J Dermatol; 2019 Apr; 58(4):440-448. PubMed ID: 30565651
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Management of non-melanoma skin cancer in solid organ transplant recipients.
    Specchio F; Saraceno R; Chimenti S; Nistico S
    Int J Immunopathol Pharmacol; 2014; 27(1):21-4. PubMed ID: 24674675
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prevalence and Types of Genital Lesions in Organ Transplant Recipients.
    Nadhan KS; Larijani M; Abbott J; Doyle AM; Linfante AW; Chung CL
    JAMA Dermatol; 2018 Mar; 154(3):323-329. PubMed ID: 29387873
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nonmelanoma skin cancer in organ transplant recipients: increase without delay after transplant and subsequent acceleration.
    Muehleisen B; Pazhenkottil A; French LE; Hofbauer GF
    JAMA Dermatol; 2013 May; 149(5):618-20. PubMed ID: 23677099
    [No Abstract]   [Full Text] [Related]  

  • 39. Accrual of non-melanoma skin cancer in renal-transplant recipients: experience of a Victorian tertiary referral institution.
    Ng JC; Cumming S; Leung V; Chong AH
    Australas J Dermatol; 2014 Feb; 55(1):43-8. PubMed ID: 23808627
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Overview on non-melanoma skin cancers in solid organ transplant recipients.
    Forchetti G; Suppa M; Del Marmol V
    G Ital Dermatol Venereol; 2014 Aug; 149(4):383-7. PubMed ID: 25068224
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 33.